These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


293 related items for PubMed ID: 16203767

  • 1. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer.
    Nagahara H, Mimori K, Utsunomiya T, Barnard GF, Ohira M, Hirakawa K, Mori M.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6800-6. PubMed ID: 16203767
    [Abstract] [Full Text] [Related]

  • 2. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z, Cai SR, He YL, Zhan WH, Chen CQ, Cui J, Wu WH, Wu H, Song W, Zhang CH, Peng JJ, Huang XH.
    Ann Surg Oncol; 2009 Jan 01; 16(1):208-19. PubMed ID: 19009246
    [Abstract] [Full Text] [Related]

  • 3. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS, Ding QQ, Guo RH, Shen H, Sun J, Lu KH, You SH, Ge HM, Shu YQ, Liu P.
    Biomed Pharmacother; 2010 May 01; 64(5):333-8. PubMed ID: 19914791
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B, Xu WB, Zheng MH, Ma JJ, Cai Q, Zhang Y, Ji J, Lu AG, Qu Y, Li JW, Wang ML, Hu WG, Liu BY, Zhu ZG.
    J Gastroenterol Hepatol; 2006 Oct 01; 21(10):1596-603. PubMed ID: 16928223
    [Abstract] [Full Text] [Related]

  • 5. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
    Pampalakis G, Prosnikli E, Agalioti T, Vlahou A, Zoumpourlis V, Sotiropoulou G.
    Cancer Res; 2009 May 01; 69(9):3779-87. PubMed ID: 19383923
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.
    Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Inoue H, Nagahara H, Murayama S, Mori M.
    Clin Cancer Res; 2005 Apr 15; 11(8):2889-93. PubMed ID: 15837738
    [Abstract] [Full Text] [Related]

  • 7. KAP1 is associated with peritoneal carcinomatosis in gastric cancer.
    Yokoe T, Toiyama Y, Okugawa Y, Tanaka K, Ohi M, Inoue Y, Mohri Y, Miki C, Kusunoki M.
    Ann Surg Oncol; 2010 Mar 15; 17(3):821-8. PubMed ID: 19898899
    [Abstract] [Full Text] [Related]

  • 8. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
    Liu P, Wang TS, You SH, Ge HM.
    Zhonghua Zhong Liu Za Zhi; 2007 Aug 15; 29(8):570-4. PubMed ID: 18210873
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M, Ito T, Tanaka E, Shimada Y.
    Ann Surg Oncol; 2007 Dec 15; 14(12):3419-27. PubMed ID: 17896150
    [Abstract] [Full Text] [Related]

  • 10. Significance of skp2 expression in primary breast cancer.
    Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M.
    Clin Cancer Res; 2006 Feb 15; 12(4):1215-20. PubMed ID: 16489076
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of ApoE expression in human gastric cancer.
    Sakashita K, Tanaka F, Zhang X, Mimori K, Kamohara Y, Inoue H, Sawada T, Hirakawa K, Mori M.
    Oncol Rep; 2008 Dec 15; 20(6):1313-9. PubMed ID: 19020708
    [Abstract] [Full Text] [Related]

  • 12. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
    Kato H, Semba S, Miskad UA, Seo Y, Kasuga M, Yokozaki H.
    Clin Cancer Res; 2004 Nov 01; 10(21):7318-28. PubMed ID: 15534108
    [Abstract] [Full Text] [Related]

  • 13. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, Yang YP, Wu CY, Shih FY, Liu CC, Lin HP, Jou YS, Lin SC, Lin CW, Chen WJ, Chan WK, Chen JJ, Yang PC.
    J Natl Cancer Inst; 2006 Jun 21; 98(12):825-38. PubMed ID: 16788156
    [Abstract] [Full Text] [Related]

  • 14. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
    Cai SR, Chen CQ, Wang Z, He YL, Cui J, Wu WH, Wu H, Zhan WH.
    Zhonghua Yi Xue Za Zhi; 2008 Aug 26; 88(33):2326-30. PubMed ID: 19087692
    [Abstract] [Full Text] [Related]

  • 15. Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
    Yang YH, Deng H, Li WM, Zhang QY, Hu XT, Xiao B, Zhu HH, Geng PL, Lu YY.
    Clin Cancer Res; 2008 Jan 01; 14(1):74-81. PubMed ID: 18172255
    [Abstract] [Full Text] [Related]

  • 16. [Preliminary study of DNA polymerase beta gene silencing by small interfering RNA in human gastric cancer BGC-823 cells].
    Zhao GQ, Wang L, Dong ZM.
    Zhonghua Zhong Liu Za Zhi; 2008 Oct 01; 30(10):729-32. PubMed ID: 19173798
    [Abstract] [Full Text] [Related]

  • 17. Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer.
    Wanajo A, Sasaki A, Nagasaki H, Shimada S, Otsubo T, Owaki S, Shimizu Y, Eishi Y, Kojima K, Nakajima Y, Kawano T, Yuasa Y, Akiyama Y.
    Gastroenterology; 2008 Aug 01; 135(2):580-90. PubMed ID: 18588891
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of low expression of Prostasin mRNA in human gastric cancer.
    Sakashita K, Mimori K, Tanaka F, Tahara K, Inoue H, Sawada T, Ohira M, Hirakawa K, Mori M.
    J Surg Oncol; 2008 Dec 01; 98(7):559-64. PubMed ID: 18932242
    [Abstract] [Full Text] [Related]

  • 19. [Expression of KLK6 protein and mRNA in primary breast cancer and its clinical significance].
    Wang SM, Mao J, Li B, Wu W, Tang LL.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov 01; 24(11):1087-9. PubMed ID: 18992199
    [Abstract] [Full Text] [Related]

  • 20. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
    Gong M, Lu Z, Fang G, Bi J, Xue X.
    Cancer Lett; 2008 Dec 08; 272(1):148-59. PubMed ID: 18694621
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.